Rapid Genetic Testing Targets Prostate Cancer Patients for New Treatments
A rapid test for advanced prostate cancer can quickly identify people with “actionable” gene variants eligible for new targeted therapies.
Read MorePosted by Andy Lundin | Mar 30, 2023 | Prostate |
A rapid test for advanced prostate cancer can quickly identify people with “actionable” gene variants eligible for new targeted therapies.
Read MorePosted by Andy Lundin | Mar 24, 2023 | Cancer |
A new study describes how we could better time when patients are tested for cancer to improve diagnostic accuracy.
Read MorePosted by Andy Lundin | Mar 24, 2023 | Cancer |
Using artificial intelligence, researchers have discovered how to screen for genetic mutations in cancerous brain tumors in under 90 seconds.
Read MorePosted by Andy Lundin | Mar 22, 2023 | Allergy & Autoimmune |
Progentec launched a study with GSK aimed at identifying people at risk of developing lupus and guiding their virtual diagnostic journey.
Read MorePosted by Andy Lundin | Mar 20, 2023 | Pancreatic |
A research team identified biomarkers that could help distinguish whether cysts on the pancreas will develop into cancer or remain benign.
Read More